ESTEMIQ
associated with 501 other trademarks
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunologic...

Words that describe this trademark:

central nervous system  nervous system endocrine  system endocrine  pharmaceutical preparations  treatment  autoimmune  preparations  cardiovascular  endocrine  gastrointestinal 

Serial Number:

88706726

Mark:

ESTEMIQ

Status:

Abandoned-No Statement of Use filed

Status Date:

06-26-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

03-31-2020

Mark Drawing Status:

Standart Character Mark

Abandon Date:

06-26-2023

Business Name:

PFIZER INC.

Correspondent Name:

Recent Trademark filings by this company